Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Regulus Therapeutics Inc. | 5,239,254 | reported | 04 Dec 2020 | tx 6+14,993,671 |
| Metacrine, Inc. | 2,734,189 | reported | 22 Dec 2021 | tx 3−497,270 |
| Mirum Pharmaceuticals, Inc. | 2,186,243 | reported | 13 Jun 2023 | tx 1−2,000,000 |
| Bright Health Group Inc. | 0 | reported | 02 Oct 2025 | tx 8+933,705−1,721,964 |
| Akouos, Inc. | 0 | reported | 30 Jun 2020 | tx 7+4,294,207−3,705,972 |
| Trevi Therapeutics, Inc. | 0 | reported | 03 Apr 2020 | tx 3+1,500,000−1,500,564 |
| GENOCEA BIOSCIENCES, INC. | 0 | reported | 25 May 2022 | tx 2−10,376,936 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Oct 2025 | OTHER | Bright Health Group Inc. | 1,159,683 | — | |
| 02 Oct 2025 | TAX_WITHHOLDING | Bright Health Group Inc. | 551 | 6.75 USD | |
| 02 Oct 2025 | EXERCISE | Bright Health Group Inc. | 372,255 | 0.01 USD | |
| 02 Oct 2025 | SALE | Bright Health Group Inc. | 280 | 6.75 USD | |
| 02 Oct 2025 | EXERCISE | Bright Health Group Inc. | 189,195 | 0.01 USD | |
| 02 Oct 2025 | GRANT_AWARD | Bright Health Group Inc. | 372,255 | — | deriv |
| 02 Oct 2025 | EXERCISE | Bright Health Group Inc. | 189,195 | 0.00 USD | deriv |
| 02 Oct 2025 | EXERCISE | Bright Health Group Inc. | 372,255 | 0.00 USD | deriv |
| 13 Jun 2023 | OTHER | Mirum Pharmaceuticals, Inc. | 2,000,000 | 0.00 USD | |
| 25 May 2022 | SALE | GENOCEA BIOSCIENCES, INC. | 4,445,093 | 0.08 USD | |
| 24 May 2022 | SALE | GENOCEA BIOSCIENCES, INC. | 5,931,843 | 0.07 USD | |
| 10 Dec 2021 | SALE | Metacrine, Inc. | 37,570 | 1.32 USD | |
| 22 Dec 2021 | SALE | Metacrine, Inc. | 288,768 | 1.00 USD | |
| 22 Dec 2021 | SALE | Metacrine, Inc. | 170,932 | 0.91 USD | |
| 04 Dec 2020 | PURCHASE | Regulus Therapeutics Inc. | 4,398,602 | 0.62 USD | |
| 04 Dec 2020 | PURCHASE | Regulus Therapeutics Inc. | 5,239,254 | 0.13 USD | deriv |
| 04 Dec 2020 | PURCHASE | Regulus Therapeutics Inc. | 258,707 | 6.22 USD | deriv |
| 30 Jun 2020 | CONVERSION | Akouos, Inc. | 1,992,238 | — | |
| 30 Jun 2020 | CONVERSION | Akouos, Inc. | 513,758 | — | |
| 30 Jun 2020 | CONVERSION | Akouos, Inc. | 1,199,976 | — | |
| 30 Jun 2020 | PURCHASE | Akouos, Inc. | 588,235 | 17.00 USD | first after silence |
| 30 Jun 2020 | CONVERSION | Akouos, Inc. | 1,199,976 | 0.00 USD | deriv |
| 30 Jun 2020 | CONVERSION | Akouos, Inc. | 513,758 | 0.00 USD | deriv |
| 30 Jun 2020 | CONVERSION | Akouos, Inc. | 1,992,238 | 0.00 USD | deriv |
| 03 Apr 2020 | SALE | Trevi Therapeutics, Inc. | 564 | 2.66 USD |
1 purchase reported after at least 12 months of silence — most recent on 30 Jun 2020.